Report Highlights
Transplant Drug Monitoring Assay Market – Scope of Report
TMR’s report on the global transplant drug monitoring assay market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global transplant drug monitoring assay market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transplant drug monitoring assay market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the transplant drug monitoring assay market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transplant drug monitoring assay market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global transplant drug monitoring assay market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transplant drug monitoring assay market.
The report delves into the competitive landscape of the global transplant drug monitoring assay market. Key players operating in the global transplant drug monitoring assay market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global transplant drug monitoring assay market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market transplant drug monitoring assay.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
- Company websites, presentations, annual reports, white papers, technical paper, product brochure
- Internal and external proprietary databases and relevant patents
- National government documents, statistical databases, and market reports
- News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
- Industry Sources:
- WorldWideScience.org
- Elsevier, Inc.
- National Institutes of Health (NIH)
- PubMed
- NCBI
- Department of Health Care Service
- Trade Data Sources
- Trade Map
- UN Comtrade
- Trade Atlas
- Company Information
- OneSource Business Browser
- Hoover’s
- Factiva
- Bloomberg
- Mergers & Acquisitions
- Thomson Mergers & Acquisitions
- MergerStat
- Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
- Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
- Helps in validating and strengthening secondary research findings
- Further develops the analysis team’s expertise and market understanding
- Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
- Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
- Purchasing/Sourcing managers, technical personnel, distributors
- Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
- Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
- Advanced Oncotherapy PLC
- Danfysik A/S
- Hitachi, Ltd.
- IBA Worldwide
- Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
- Table 1 : Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031
- Table 2 : Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
- Table 3 : Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031
- Table 4 : Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031
- Table 5 : Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Table 6 : Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Region, 2017–2031
- Table 7 : North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country, 2017–2031
- Table 8 : North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031
- Table 9 : North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
- Table 10 : North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031
- Table 11 : North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031
- Table 12 : North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Table 13 : Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 14 : Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031
- Table 15 : Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
- Table 16 : Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031
- Table 17 : Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031
- Table 18 : Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Table 19 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 20 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031
- Table 21 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
- Table 22 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031
- Table 23 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031
- Table 24 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Table 25 : Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 26 : Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031
- Table 27 : Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
- Table 28 : Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031
- Table 29 : Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031
- Table 30 : Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Table 31 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
- Table 32 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031
- Table 33 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031
- Table 34 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031
- Table 35 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031
- Table 36 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031
- Figure 1 : Global Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031
- Figure 2 : Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031
- Figure 3 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Consumables, 2017–2031
- Figure 4 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Equipment, 2017–2031
- Figure 5 : Global Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031
- Figure 6 : Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031
- Figure 7 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Immunoassays, 2017–2031
- Figure 8 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Chromatography-MS, 2017–2031
- Figure 9 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Others, 2017–2031
- Figure 10 : Global Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031
- Figure 11 : Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031
- Figure 12 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Tacrolimus, 2017–2031
- Figure 13 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Methotrexate, 2017–2031
- Figure 14 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Cyclosporin, 2017–2031
- Figure 15 : Global Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031
- Figure 16 : Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 17 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Hospital Laboratories, 2017–2031
- Figure 18 : Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Commercial & Private Laboratories, 2017–2031
- Figure 19 : Global Transplant Drug Monitoring (TDM) Assay Market, by Region, 2021 and 2031
- Figure 20 : Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Region, 2022–2031
- Figure 21 : North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031
- Figure 22 : North America Transplant Drug Monitoring (TDM) Assay Market, by Country, 2021 and 2031
- Figure 23 : North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country, 2022–2031
- Figure 24 : North America Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031
- Figure 25 : North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031
- Figure 26 : North America Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031
- Figure 27 : North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031
- Figure 28 : North America Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031
- Figure 29 : North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031
- Figure 30 : North America Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031
- Figure 31 : North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 32 : Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031
- Figure 33 : Europe Transplant Drug Monitoring (TDM) Assay Market, by Country/Sub-region, 2021 and 2031
- Figure 34 : Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 35 : Europe Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031
- Figure 36 : Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031
- Figure 37 : Europe Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031
- Figure 38 : Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031
- Figure 39 : Europe Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031
- Figure 40 : Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031
- Figure 41 : Europe Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031
- Figure 42 : Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 43 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031
- Figure 44 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by Country/Sub-region/Sub-region, 2021 and 2031
- Figure 45 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 46 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031
- Figure 47 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031
- Figure 48 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031
- Figure 49 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031
- Figure 50 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031
- Figure 51 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031
- Figure 52 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031
- Figure 53 : Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 54 : Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031
- Figure 55 : Latin America Transplant Drug Monitoring (TDM) Assay Market, by Country/Sub-region, 2021 and 2031
- Figure 56 : Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 57 : Latin America Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031
- Figure 58 : Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031
- Figure 59 : Latin America Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031
- Figure 60 : Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031
- Figure 61 : Latin America Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031
- Figure 62 : Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031
- Figure 63 : Latin America Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031
- Figure 64 : Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 65 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031
- Figure 66 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by Country/Sub-region, 2021 and 2031
- Figure 67 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
- Figure 68 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031
- Figure 69 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031
- Figure 70 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031
- Figure 71 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031
- Figure 72 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031
- Figure 73 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031
- Figure 74 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031
- Figure 75 : Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031
- Figure 76 : Global Transplant Drug Monitoring (TDM) Assay Market Share Analysis/Ranking, by Company, 2021
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More